TTTatyana Ivanovna Tverdokhlebova

Tatyana Ivanovna Tverdokhlebova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tatyana Ivanovna Tverdokhlebova has a total of 144 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Epidemiological aspects of organizing HIV screening in southern Russia

    by A. N. Matuzkova, E. A. Sklyanaya, A. G. Suladze, E. A. Shevchenko, E. A. Gapon, T. I. Tverdokhlebova, А. Н. Матузкова, Е. А. Скляная, А. Г. Суладзе, Е. А. Шевченко, et al.

    Objective: to assess the dynamics of HIV testing coverage, the structure of surveyed populations, and the frequency of detection of HIV markers among the population of Southern Russia. Materials and methods: the analysis of data from federal statistical observation form No. 4 ≪Information on the results of blood tests for HIV antibodies≫ for 2020–2025 was carried out for 15 constituent entities of the Russian Federation, which are part of the Southern and North Caucasus Federal Districts. Results: in the South of Russia, the coverage of HIV screening has increased annually since 2020 and amounted to 34% by 2026. In contrast, the frequency of HIV infection detection decreased by 1.7 times. A significant reduction in the risk-based nature of HIV serological screening was noted, as the proportion of individuals from the most vulnerable groups in the Southern and North Caucasian Federal Districts surveyed with respect to HIV infection was only 2.0Ѓ}0.04% and 1.4Ѓ}0.05%, respectively. However, the HIV detection rate in these population groups is significantly higher than in the general population. Conclusion: targeted risk-based selection of population groups for HIV serological screening is strategically important for ensuring early diagnosis of HIV infection.

  • Seasonal Variation in the Mutagenic and Oxidative Properties of Gut Microbiota in Active and Hibernating Common Noctules (Nyctalus noctula)

    by Sergey A. Emelyantsev, Ilia V. Popov, Evgeniya V. Prazdnova, Iraida S. Berezinskaia, Irina B. Koroleva, Vladislav E. Gorobets, Inna S. Tsurkova, Anna V. Aleshukina, Tatiana I. Tverdokhlebova, Michael L. Chikindas, et al.

  • Epidemiological and Clinical Aspects of Visceral Toxocariasis in the Russian Federation

    by V. V. Pushkarnaya, I. V. Khutoryanina, L. A. Ermakova, T. O. Kochoyan, T. I . Tverdokhlebova

    Relevance . Toxocariasis is a geohelminthiasis caused by the larval stage of nematodes of the genus Toxocara, characterized by ubiquitous spread. The disease is socially significant, as it reflects the level of social and hygienic well-being of the population. Aim . study was to determine the actual epidemiological situation of visceral toxocariasis in Russia based on a comprehensive analysis of official statistics, seroepidemiological, and sanitary-parasitological studies. Materials and Methods . An analysis of the epidemiological situation of toxocariasis in the Russian Federation for 2024 was conducted using data from the Unified Information and Analytical System «Personalized Accounting of Infectious Diseases» module and 865 epidemiological survey cards from toxocariasis outbreaks received by the Reference Center for Monitoring Larval Helminthiasis. Evaluation of the obtained data from the seroepidemiological survey of conditionally healthy individuals and sanitary-parasitological studies of epidemiologically significant environmental objects conducted in several regions of the Russian Federation in 2024. Results . Problem areas were identified where significant discrepancies were observed between the registered incidence rate, the seroprevalence of the population for T. canis, and the degree of contamination of epidemiologically significant environmental objects.

  • Epidemiological genomic surveillance of COVID-19 in the Rostov Region

    by A.R. Litovko, A.N. Matuzkova, D.S. Kolpakov, A.G. Suladze, T.I. Tverdokhlebova, T.I. Tverdokhlebova

    Objective. To study the characteristics of the COVID-19 epidemic in the Rostov Region in 2020–2024 using genomic monitoring. Materials and methods. A retrospective epidemiological analysis of COVID-19 incidence in the Rostov Region from 2020 to 2024 was conducted. The clinical and diagnostic laboratory of the Rostov Research Institute of Microbiology and Parasitology of Rospotrebnadzor identified SARS-CoV-2 and determined its genetic diversity (2,901 clinical samples were examined). Results. During the observation period, changes in the biological properties of SARS-CoV-2 were noted. The incidence of COVID-19 in the Rostov region, as in the country as a whole, was uneven. Nine periods of increase, stabilization, and decrease in COVID-19 incidence were identified. The peak incidence most often occurs at the beginning of the year and in the fall. During the circulation of the Omicron strain, a milder clinical course and a decrease in the number of hospitalized patients were observed. Conclusion. After the peak of the COVID-19 wave, there was a decrease in the intensity of fluctuations in the number of cases against the backdrop of a sharp decline in mortality. During 2024, there was a decrease in COVID-19 incidence compared to previous years. The continuation of the COVID-19 epidemic in the Rostov Region in 2024 was due to the dominance of new Omicron SARS-CoV-2 subvariants (XBB.1.5/XBB.1.9.1; JN.1; LF.7.1.3; KP.3.1.1 and KP.2.3.). Key words: COVID-19, genomic monitoring, epidemic process, SARS-CoV-2, gene variants, Rostov Region

  • On the epidemiological situation on trichinellosis in the Russian Federation

    by M.P. Chernikova, I.V. Khutoryanina, O.S. Dumbadze, T.I. Tverdokhlebova

    The objective is to study the epidemiologic situation of trichinellosis in the Russian Federation in 2024. Materials and methods. A retrospective epidemiological analysis of trichinellosis morbidity in the Russian Federation for the period 2010–2024 was carried out, the analysis of maps of epidemiological survey of trichinellosis focus for 2019–2024 was carried out, the analysis of the results of veterinary and sanitary examination for the year 2024, received at the request of the Reference Center for monitoring of larval helminthoses from territorial bodies of Rospotrebnadzor was carried out. Results. In the Russian Federation in 2024, 61 cases of trichinellosis were registered, with an incidence rate of 0.04 per 100,000 population. In 2024, trichinellosis was registered on the territory of 25 subjects of the Russian Federation. The highest number of cases was registered in the Far Eastern and Northwestern Federal Districts. According to the epidemiological survey maps (ESM) of trichinellosis cases reported to the Reference Center for Monitoring Larval Helminthiasis, within the social structure, the working population accounted for the highest number of cases in 2024, 33.8%. In 45.5% of cases, the ill persons were hospitalized. In 31.1% of cases, there was a history of consumption of domestic pig meat prepared by various cooking methods. In another 19.7% of cases, consumption of wild boar meat, 4.9% of brown bear meat, and 3.3% of elk meat was noted. According to the ESM data, these products are the most likely factors of transmission. According to the received results of veterinary and sanitary examination of meat samples for trichinellosis from farm and wild animals from 54 subjects of the Russian Federation, positive results were found in Ryazan, Kirov, Tomsk regions, in the Republics of Bashkortostan, Udmurtia, Khakassia, Sakha (Yakutia). Conclusion. The epidemiologic situation on trichinellosis in the Russian Federation remains tense, which is confirmed by the data of 2024. Trichinellosis, taking into account the severity of the course, the possibility of group diseases in the Russian Federation retains its epidemiologic potential and socio-economic significance. Timely clinical diagnosis remains unsatisfactory, which negatively affects the quality of treatment and prevents prompt anti-epidemic and preventive measures. The detection of trichinella larvae in the meat of wild animals in different subjects of the Russian Federation by the veterinary and sanitary service in each month of 2024 indicates an epizootological malaise and, as a consequence, a continuing risk of infection of the population. Key words: trichinellosis, morbidity, epidemiologic situation, Trichinella spp.


  • Open Access

    Immunogenicity analysis of a composition of inactivated human rotavirus A strains in mice following immunisation

    by M. V. Kovrizhko, E. P. Kolpakova, D. S. Kolpakov, T. I. Tverdokhlebova, E. S. Kurbatov

    INTRODUCTION. Currently, rotavirus infection is prevented with live attenuated vaccines. However, international and Russian vaccination practices, as well as the physiological characteristics of paediatric patients, necessitate the development of inactivated rotavirus vaccines. Prerequisites for the development of such vaccines are the availability of virus strains capable of stable replication and the selection of optimal inactivation conditions providing for the required antigenicity and immunogenicity levels.AIM. This study aimed to evaluate and compare the characteristics of the rotavirus-specific immune response to native strains and to a composition of inactivated rotavirus A strains in a mouse model.MATERIALS AND METHODS. The study used human rotavirus A strains (RRV-4, RRV-5, RRV-6, and RRV-7), a standard rotavirus strain (SA-11 NVC 2364, National Virus Collection of the Russian Federation), and cultures of pig embryo kidney cells treated with Versene solution (SPEV) and Vero cells. Virus titration was used to determine the infectivity of the strains grown in Vero cells maintained in continuous culture. The authors monitored infected cell cultures up to the onset of the cytopathic effect, calculated the 50% tissue culture infectious dose (TCID50) by the Kärber method modified by Ashmarin, and expressed the results as log10 TCID50/mL. Virus strains were inactivated with formaldehyde. To evaluate immuno­genicity, outbred white mice were immunised with native strains and the composition of inactivated strains (RRV-4, RRV-5, RRV-6, and RRV-7). After immunisation, blood was taken from the animals, and the serum titre of rotavirus A antibodies was determined by indirect heterogeneous enzyme immunoassay.RESULTS. The infectivity of the rotavirus strains adapted to Vero cells ranged from 8.9 to 7.9 log10 TCID50/mL. When selecting inactivation conditions, the authors showed that inactiva­tion occurred at a temperature of 37 °C and a formaldehyde concentration of 0.05–0.025% (depending on the duration of treatment). The antigenicity analysis demonstrated that the antigen titre of the inactivated strain composition (1:16) was lower than that of native strains (1:32–1:64). The authors demonstrated comparability of immunogenicity profiles of the inacti­vated strain composition and native strains in mice.CONCLUSIONS. The study generated candidate rotavirus A strains that exhibited stable replica­tion in continuous cultures of Vero cells. The authors selected optimal inactivation conditions for these rotavirus strains and developed an inactivated strain composition showing antigenicity and immunogenicity. The presented data suggest that the composition of inactivated rotavirus A strains can be considered as a basis for further development of an inactivated rotavirus vaccine.

  • Open Access

    The Rostov-on-Don Anti-Plague Institute and it’s 90 years of scientific and practical cooperations

    by A. K. Noskov, E. V. Kovalev, G. V. Karpushchenko, O. S. Chemisova, O. F. Kretenchuk, M. V. Poleeva, O. A. Noskovа, Е. I. Glushchenko, T. I. Tverdokhlebova, A. R. Kvasov

    Objective: to form a brief overview of data on the interactions of the Rostov-on-Don Anti-plague Research Institute with the other state institutions ensuring the sanitary and epidemiological population wellbeing.Materials and methods: analysis of archive materials and literature sources from databases and electronic libraries such as E-library, CyberLeninka, etc.Results: We have described the main directions of the interactions of the Rostov-on-Don Anti-plague Research Institute with the institutions of Rospotrebnadzor (Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing) and the Ministry of Health of the Russian Federation, that have been directed on realization of collaborative studies, planning of cooperative publications, organizing and conducting advisory, methodological and practical assistance. Special attention has been paid to the activities that bring together specialists from both research and educational institutions and practical health-care in the Rostov region.Conclusion: Coordinated actions of specialists from the Rostov-on-Don Anti Plague Research Institute with the bodies and organizations of Rospotrebnadzor, Ministry of Health of the Russian Federation on improvement of epidemiological surveillance, diagnostics and prevention of infectious diseases allow us to carry out effective surveillance of especially dangerous infections and to promote improvement of professional level of profile specialists.


  • Open Access

    The current situation of echinococcosis in the Far East and South of Russia

    by A. G. Dragomeretskaya, O. E. Trotsenko, F. V. Logvin, T. I. Tverdokhlebova, E. B. Romanova, I. V. Ishchenkova, Yu. I. Moskvina, L. L. Dimidova, M. P. Chernikova

    Objective:to assess the epidemic situation of echinococcosis in the period 2012–2022 in the endemic territories of the Far Eastern Federal District and South of Russia.Materials and methods:based on the data of the annual statistical reporting forms No. 2 "Information on infectious and parasitic diseases", data from the Reference Center for Monitoring Larval Helminthiasis of Rostov Research Institute Microbiology and Parasitology of Rospotrebnadzor, an analysis of the incidence of echinococcosis in the territories of the Far East and South of Russia in the period 2012–2022 was carried out. For seroepidemiological examination of a conditionally healthy population by the ELISA method, the diagnostic kit "Echinococcus-IgG-ELISA-BEST" (JSC "Vector-Best", Novosibirsk) was used.Results:it is shown that the epidemiological situation of echinococcosis is characterized by pronounced territorial unevenness. In the south of Russia, epidemiological problems with echinococcosis persisted in Kalmykia (0.74–2.19 cases per 100,000 population) and in the Astrakhan region (0.60–1.48 cases per 100,000 population). Among the relatively healthy population, the average seropositivity to E.granulosus antigens in the Far East was 5.8%, in the south of Russia — 2,6%. Conclusions: the data obtained indicate an unfavorable epidemiological situation for echinococcosis in a number of regions of the Far East and South of Russia.


  • Open Access

    About the history of medical societies in Russia — Rostov Regional Branch of the All-Russian Scientific and Practical Society of Epidemiologists, Microbiologists and Parasitologists

    by A. K. Noskov, S. V. Shlyk, G. G. Kharseeva, F. V. Logvin, E. V. Kovalev, N. V. Shitova, T. I. Tverdokhlebova, E. D. Teplyakova, V. V. Batashev, O. F. Kretenchuk, et al.

    Objective: to form a brief overview of data on the main historical stages in the development of medical societies in Russia and the contribution of the Rostov branch of the All-Russian Scientific and Practical Society of Epidemiologists, Microbiologists and Parasitologists to ensuring the sanitary and epidemiological well-being of the population. Materials and methods: analysis of archival materials and literary sources from the databases of electronic libraries e-library, CyberLeninka and others. Results: the contribution of medical societies to the development of domestic medicine and the sanitary and epidemiological service of our country is indicated. Particular attention is paid to the activities of the Rostov regional branch of the All-Russian Scientific and Practical Society of Epidemiologists, Microbiologists and Parasitologists, which brought together specialists from both research and educational institutions, and practical health care of the Don region. Conclusion: The results of practical undertakings and scientific research of medical societies throughout their existence contributed to the development of preventive medicine and were focused on protecting the health of the country's population. The activities of the Rostov Regional Branch of the All-Russian Scientific and Practical Society of Epidemiologists, Microbiologists and Parasitologists are aimed not only at developing domestic medical science and promoting achievements among the medical community and the population, but also at improving the professional level of specialized specialists, developing and implementing effective scientific, practical, educational technologies .


  • Open Access

    Comparative evaluation of the effectiveness of narlaprevir in the composition of interferon and interferon-free treatment regimens for patients with chronic hepatitis C

    by Irina P. Grushko, Elena B. Romanova, Tatiana I. Tverdokhlebova, Marina N. Gapon, Svetlana Y. Vodyanitskaya, Твердохлебова Татьяна Ивановна

    Aim. Our aim was to give a comparative assessment of the effectiveness of using narlaprevir in combination with pegylated interferon-alpha-2a (Peg-IFN-alpha-2a) and interferon-free mode in patients with chronic hepatitis C (CHC). Materials and methods. The prospective cohort study included 187 patients infected with genotype 1b of hepatitis C virus. Of these, 107 (the 1st group of patients) received narlaprevir 200 mg once a day, ritonavir 100 mg once a day, Peg-IFN-alpha-2a 180 mkg subcutaneously once a week and ribavirin at a dose depending on body weight (10001200 mg per day) for 12 weeks, and then the standart "dual" therapy (Peg-IFN-alpha-2a + ribavirin) was continued until 24 weeks. Patients of the 2nd group (n=80) received antiviral therapy in an interferon-free mode. They received narlaprevir 200 mg once daily, ritonavir 100 mg once daily, and daclatasvir 60 mg once daily for 12 weeks. Results. With the use of an interferon-containing treatment regimen, a sustained virological response was achieved in 92.4% of previousle untreated patients with CH and in 66.7% patients with "unsuccessful" experience of the previous course of treatment. In 5.6% of cases, there was an early termination of treatment due to the development of adverse events. 80 (100%) patients completed the course of treatment with narlaprevir in the interferon-free mode. Sustained virological response was reached by 75 (90%) patients. Conclusion. Real clinical practice indicates that the use of narlaprevir in the non-interferon mode is not inferior in efficiency to the interferon-containing treatment regimen and demonstrates a more favorable safety profile.